Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 637415, 9 pages
http://dx.doi.org/10.1155/2014/637415
Research Article

rhPDGF-BB Promotes Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells from Streptozotocin-Induced Diabetic Rats through ERK Pathway

1Department of Prosthodontics, Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai 200011, China
2Department of Stomatology, Shanghai East Hospital Affiliated to Tongji University, Shanghai 200011, China
3Shanghai Stomatological Diseases Center, Shanghai 200001, China
4Department of Oral and Maxillofacial Surgery, Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
5Oral Bioengineering Laboratory/Regenerative Medicine Lab, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai 200011, China

Received 30 April 2013; Revised 30 September 2013; Accepted 27 November 2013; Published 29 January 2014

Academic Editor: Eiichi Hinoi

Copyright © 2014 Yanfang Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” The Journal of the American Medical Association, vol. 310, no. 9, pp. 948–959, 2013. View at Publisher · View at Google Scholar
  2. M. J. Silva, M. D. Brodt, M. A. Lynch et al., “Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life,” Journal of Bone and Mineral Research, vol. 24, no. 9, pp. 1618–1627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Janghorbani, R. M. van Dam, W. C. Willett, and F. B. Hu, “Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture,” The American Journal of Epidemiology, vol. 166, no. 5, pp. 495–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Yaturu, “Diabetes and skeletal health,” Journal of Diabetes, vol. 1, no. 4, pp. 246–254, 2009. View at Google Scholar · View at Scopus
  5. L. Cozen, “Does diabetes delay fracture healing?” Clinical Orthopaedics and Related Research, vol. 82, pp. 134–140, 1972. View at Google Scholar · View at Scopus
  6. A. M. Herskind, K. Christensen, K. Norgaard-Andersen, and J. F. Andersen, “Diabetes mellitus and healing of closed fractures,” Diabete et Metabolisme, vol. 18, no. 1, pp. 63–64, 1992. View at Google Scholar · View at Scopus
  7. P. Vestergaard, “Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis,” Osteoporosis International, vol. 18, no. 4, pp. 427–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Harada and G. A. Rodan, “Control of osteoblast function and regulation of bone mass,” Nature, vol. 423, no. 6937, pp. 349–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. C. Hofbauer, C. C. Brueck, S. K. Singh, and H. Dobnig, “Osteoporosis in patients with diabetes mellitus,” Journal of Bone and Mineral Research, vol. 22, no. 9, pp. 1317–1328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. L. R. McCabe, “Understanding the pathology and mechanisms of type I diabetic bone loss,” Journal of Cellular Biochemistry, vol. 102, no. 6, pp. 1343–1357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Ogasawara, A. Nakajima, F. Nakajima, K. Goto, and M. Yamazaki, “Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat,” Bone, vol. 43, no. 5, pp. 832–839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Khosla, J. J. Westendorf, and U. I. Mödder, “Concise review: insights from normal bone remodeling and stem cell-based therapies for bone repair,” Stem Cells, vol. 28, no. 12, pp. 2124–2128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Mauney, V. Volloch, and D. L. Kaplan, “Role of adult mesenchymal stem cells in bone tissue-engineering applications: current status and future prospects,” Tissue Engineering, vol. 11, no. 5-6, pp. 787–802, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. F. Zhao, D. L. Zeng, L. G. Xia et al., “Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats,” International Journal of Molecular Medicine, vol. 31, no. 3, pp. 614–620, 2013. View at Publisher · View at Google Scholar
  15. A. Stolzing, D. Sellers, O. Llewelyn, and A. Scutt, “Diabetes induced changes in rat mesenchymal stem cells,” Cells Tissues Organs, vol. 191, no. 6, pp. 453–465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. O. Hollinger, C. E. Hart, S. N. Hirsch, S. Lynch, and G. E. Friedlaender, “Recombinant human platelet-derived growth factor: biology and clinical applications,” Journal of Bone and Joint Surgery A, vol. 90, supplement 1, pp. 48–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. W. A. Tyndall, H. A. Beam, C. Zarro, J. P. O'Connor, and S. S. Lin, “Decreased platelet derived growth factor expression during fracture healing in diabetic animals,” Clinical Orthopaedics and Related Research, no. 408, pp. 319–330, 2003. View at Google Scholar · View at Scopus
  18. M. Nevins, W. V. Giannobile, M. K. McGuire et al., “Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial,” Journal of Periodontology, vol. 76, no. 12, pp. 2205–2215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. I. Caplan and D. Correa, “PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs,” Journal of Orthopaedic Research, vol. 29, no. 12, pp. 1795–1803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. S. McCarthy, J. H. H. Williams, M. W. J. Davie, and M. J. Marshall, “Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells,” Journal of Cellular Physiology, vol. 218, no. 2, pp. 350–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. O. Hollinger, A. O. Onikepe, J. MacKrell et al., “Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable β-tricalcium phosphate/collagen matrix,” Journal of Orthopaedic Research, vol. 26, no. 1, pp. 83–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Xu, K. Lv, W. Zhang, X. Zhang, X. Jiang, and F. Zhang, “The healing of critical-size calvarial bone defects in rat with rhPDGF-BB, BMSCs, and β-TCP scaffolds,” Journal of Materials Science: Materials in Medicine, vol. 23, no. 4, pp. 1073–1084, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Al-Zube, E. A. Breitbart, J. P. O'Connor et al., “Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and β-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model,” Journal of Orthopaedic Research, vol. 27, no. 8, pp. 1074–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Retzepi, M. P. Lewis, and N. Donos, “Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration,” Clinical Oral Implants Research, vol. 21, no. 1, pp. 71–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Lü, D. Zeng, Y. Zhang et al., “BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative,” Annals of Biomedical Engineering, vol. 39, no. 6, pp. 1829–1839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Jiang, J. Zhao, S. Wang et al., “Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs,” Biomaterials, vol. 30, no. 27, pp. 4522–4532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Retzepi and N. Donos, “The effect of diabetes mellitus on osseous healing,” Clinical Oral Implants Research, vol. 21, no. 7, pp. 673–681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. A. Breitbart, S. Meade, V. Azad et al., “Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus,” Journal of Orthopaedic Research, vol. 28, no. 7, pp. 942–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Khan, S. Akhtar, S. Mohsin, S. N. Khan, and S. Riazuddin, “Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells,” Stem Cells and Development, vol. 20, no. 1, pp. 67–75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Cramer, E. Freisinger, R. K. Jones et al., “Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells,” Stem Cells and Development, vol. 19, no. 12, pp. 1875–1884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Mezawa, S. Araki, H. Takai et al., “Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB,” Gene, vol. 435, no. 1-2, pp. 80–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Haque, H. Uludag, R. F. Zernicke, S. R. Winn, and W. Sebald, “Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein 2 treatment in vitro,” Tissue Engineering, vol. 11, no. 3-4, pp. 634–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Mehrotra, S. M. Krane, K. Walters, and C. Pilbeam, “Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells,” Journal of Cellular Biochemistry, vol. 93, no. 4, pp. 741–752, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. R. T. Franceschi, C. Ge, G. Xiao, H. Roca, and D. Jiang, “Transcriptional regulation of osteoblasts,” Annals of the New York Academy of Sciences, vol. 1116, pp. 196–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Komori, “Regulation of skeletal development by the Runx family of transcription factors,” Journal of Cellular Biochemistry, vol. 95, no. 3, pp. 445–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Gharibi, M. S. Ghuman, and F. J. Hughes, “Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRbeta-induced MSC self-renewal,” Journal of Cellular and Molecular Medicine, vol. 16, no. 11, pp. 2789–2801, 2012. View at Publisher · View at Google Scholar
  37. C. Ge, G. Xiao, D. Jiang, and R. T. Franceschi, “Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development,” Journal of Cell Biology, vol. 176, no. 5, pp. 709–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Xiao, D. Jiang, P. Thomas et al., “MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1,” The Journal of Biological Chemistry, vol. 275, no. 6, pp. 4453–4459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Ge, Q. Yang, G. Zhao, H. Yu, K. L. Kirkwood, and R. T. Franceschi, “Interactions between extracellular signal-regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity,” Journal of Bone and Mineral Research, vol. 27, no. 3, pp. 538–551, 2012. View at Publisher · View at Google Scholar · View at Scopus